Start Willow vs Ro.co: oral Wegovy vs compounded semaglutide

Start Willow vs Ro.co is primarily a choice between a compounded injectable semaglutide pathway and an FDA-approved oral option. Quick verdict: choose Start Willow if you want a direct-pay, no-insurance compounded semaglutide program with fast shipping; choose Ro.co if you need the FDA-approved Wegovy pill or prefer an oral, branded alternative.

Start Willow: Learn about compounded semaglutide from $249/mo

Head-to-head: what differs most between Start Willow and Ro.co

This comparison focuses on the most distinctive differences supported by the sources: medication type and regulatory status, pricing and entry cost, shipping and delivery commitments, insurance and membership requirements, and platform positioning for injection-averse patients.

Medication type and regulatory status

Start Willow: offers a once-weekly compounded semaglutide injection described as a customized treatment option. The source explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Start Willow positions its product as a compounded alternative comparable to Ozempic and tirzepatide, prescribed after an online clinician review.

Ro.co: offers the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication on this list. The source highlights that Ro is the only mainstream platform here with access to the Wegovy pill, providing an FDA-approved finished medication rather than a compounded injectable. Treatment is available only when a licensed clinician determines it is medically appropriate.

Pricing and how you get started

Start Willow: marketed “From $249 per Month” with a noted pricing detail that patients pay $249 for the first month and $299/month ongoing. The source frames the $299 ongoing rate as on the higher end of the list and notes there are no membership fees and no insurance required.

Ro.co: advertises “Get Started Online for Just $39.” The source states ongoing branded medication pricing varies and can be higher than compounded alternatives. Ro discloses pricing before you complete the consultation and says there are no hidden fees.

Shipping speed and fulfillment

Start Willow: guarantees delivery in 3 days or less from its licensed pharmacy network and promotes same-day prescriptions and free 2-Day shipping in captured landing-page evidence. This 3-day delivery commitment is presented as one of the faster delivery commitments among GLP-1 telehealth platforms.

Ro.co: shipping or fulfillment timing was not verified on the captured page. The source does not supply a comparable delivery guarantee in the provided evidence.

Insurance, membership, and platform positioning

Start Willow: operates a direct-pay model that requires no insurance and charges no membership fees. The source emphasizes that this model bypasses insurance pre-authorization and is positioned for patients frustrated by prior-authorization denials, particularly for Ozempic used for weight loss.

Ro.co: offers a direct-pay entry point at $39 and discloses pricing up front. The source notes insurance coverage for GLP-1 weight loss medication is inconsistent and often denied for weight loss alone; ongoing branded medication pricing depends on the plan.

Comparison table

Practical differences in patient experience

Injection route vs oral route is the clearest patient-facing contrast. Ro.co highlights the Wegovy pill as an injection-free, FDA-evaluated option that removes needle aversion for some patients. Start Willow emphasizes personalized, clinician-guided compounded semaglutide injections, with written and video instructions and same-week shipping for patients prioritizing speed and a direct-pay path without insurance.

Ro.co: See Wegovy pill access and start at $39

Safety and regulatory notes to weigh

Start Willow explicitly warns that its compounded semaglutide is not FDA-approved and that compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. Ro.co emphasizes that its Wegovy pill is FDA-approved as a finished medication, offering regulatory assurance according to the source. Where the source lacks evidence on specific shipping or ongoing pricing details for Ro.co, it is noted as not verified on the captured page.

Start Willow: Explore the compounded semaglutide program

Conclusion: Start Willow vs Ro.co

Start Willow vs Ro.co comes down to compounded injectable access with fast shipping and a no-insurance direct-pay model versus an FDA-approved oral Wegovy pill and a low-cost $39 entry point. The primary trade-offs are regulatory status, medication form, starting and ongoing costs, and delivery commitments. The primary keyword Start Willow vs Ro.co appears here to summarize those contrasts.

Ro.co: Learn more about the Wegovy pill and pricing

Choose Start Willow if…

• You want a direct-pay, no-insurance option for a compounded semaglutide injectable with a documented 3-day delivery commitment and no membership fees.
• You accept that compounded medications are not FDA-approved and prefer a clinician-personalized compounded regimen and fast fulfillment.

Choose Ro.co if…

• You prefer an FDA-approved, finished medication in oral form and want access to the Wegovy pill or you are injection-averse.
• You value an established platform that discloses pricing up front and offers a low-cost $39 entry point before treatment decisions.